Atlas Trials

Evaluating the Efficacy of Opti-Speech for Speech Treatment

Clinical trial NCT02705326 · COMPLETED

Trial details

NCT number
NCT02705326
Sponsor
Vulintus, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Articulation DisorderDysarthriaPrelingual Deafness
Start date
2016-01-01
Primary completion
2018-08-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.